Senior Director of Population Health Strategy & Analytics
Job Description
Key Skills Required
Master these to land this role
Want to know if you're a match for this job?
What You'll Do
The Senior Director of Population Health Strategy & Analytics will lead the development of enterprise-wide population health strategies that optimize the clinical, economic, and societal impact of BridgeBio therapies. This role integrates advanced analytics, real-world data, healthcare delivery insights, and strategic planning to inform decisions across the product lifecycle.
This individual focuses on translating diverse sources of evidence into actionable strategies that improve patient identification, treatment access, health system integration, and measurable population outcomes for BBIO therapies. The Senior Director will identify opportunities to improve care pathways, reduce diagnostic delays, quantify healthcare system impact of BBIO therapies, and enable data-driven decision making for rare disease populations.
Responsibilities
- Develop long-term population health strategies and identify opportunities to improve diagnosis, referral pathways, treatment initiation, and long-term patient outcomes supporting both pipeline and commercial assets
- Lead identification of data platforms and advanced analytics that inform population health strategy and commercial decision making
- Use claims, EHR, registry, genomic, and social determinants of health data to drive disease awareness, patient finding, and outcomes tracking for IDNs and payers
- Partner with Integrated Delivery Networks (IDNs), Centers of Excellence, and health systems to understand care delivery challenges and assess opportunities for improvement and design strategies that facilitate integration of BridgeBio therapies into care models for relevant therapeutic areas
- Through advanced analytics, enable early identification and outcomes tracking at the individual health system and payer level to ensure value demonstration
- Collaborate across BridgeBio teams including HEOR, Market Access, Medical, Commercial, Clinical Development and Corporate Strategy to engage with health systems, payers, provider organizations, public health leaders, and academic collaborators
Where You'll Work
This is a remote position with 20-30% travel expected
Who You Are
- Advanced degree (PhD, PharmD, MD, MPH, DrPH, MBA, or equivalent).
- 10+ years in biotechnology, pharmaceuticals, healthcare analytics, health systems, consulting, or population health
- Experience translating complex healthcare data into business strategy and actionable insights
- Strong understanding of:
- Rare disease ecosystems
- Healthcare delivery
- Population analytics
- Patient journey analytics
- Health policy
- Commercial strategy
- Proven track record of strong collaboration and demonstrated leadership in matrix organizations
Preferred experience in one or more of:
- Population Health Management and Value-Based Care
- Healthcare Strategy
- Integrated Delivery Networks
- Health Systems Analytics
- Digital Health
- HEOR
How would you rate this job post?
See what other professionals think about this role.
Similar Opportunities
More Openings at BridgeBio
Explore Top Companies in this Space
Sailor Health
HealthTech / Mental Health / Senior Care
Assort Health
HealthTech / Artificial Intelligence / Healthcare / SaaS
Nabla
HealthTech / Artificial Intelligence / Healthcare IT
Velsera
HealthTech / Precision Medicine / Bioinformatics / SaaS
BridgeBio
View Company ProfileBridgeBio is a premier, enterprise-grade biopharmaceutical organization engineered to orchestrate massive-scale drug discovery and commercialization for rare genetic diseases and targeted oncology. Operating as a high-velocity biomedical ecosystem, the company eliminates the operational friction of traditional pharmaceutical R&D by utilizing a decentralized, highly agile therapeutic development model. Moving beyond legacy clinical silos, BridgeBio seamlessly connects robust genomic insights with rapid translational science to bring transformative medicines like Attruby® and NULIBRY® to market. Under the hood, their highly scalable pipeline infrastructure accelerates the progression of complex investigational compounds—ranging from limb-girdle muscular dystrophy to achondroplasia therapies—through rigorous, data-driven clinical trials. What sets BridgeBio apart is its uncompromising dedication to patient-centric acceleration; by bridging the gap between cutting-edge genetic research and rapid commercial deployment, the firm empowers top-tier scientific innovators to dramatically reduce the time-to-market for life-saving precision therapeutics without sacrificing rigorous clinical integrity.
Safety First
- Never pay for a job application.
- Do not share sensitive bank info.
- Verify the client before starting work.

